Telegram Group & Telegram Channel
科济药业 Claudin18.2 CAR-T 拟纳入优先审评,针对胃癌

舒瑞基奥仑赛注射液(CT041)是科济药业开发的靶向Claudin18.2蛋白的自体CAR-T细胞产品,该蛋白在胃癌和胰腺癌中表达率超50%,适合治疗晚期胃/食管胃结合部腺癌。2020年9月,CT041获美国FDA孤儿药资格认定用于胃癌/食管胃结合部腺癌治疗。

媒体报道
科济药业-B现涨逾3% 子公司申报的舒瑞基奥仑赛注射液拟纳入优先审评 新浪科技
科济药业 Claudin18.2 CAR-T 拟纳入优先审评,针对胃癌 医药魔方
治疗胃癌,科济药业CAR-T细胞疗法拟纳入优先审评! 医药魔方
潜在首款!科济药业CAR-T疗法拟纳入优先审评 医药魔方

事件追踪
2025-02-26 科济药业引入珠海软银欣创投资以加速通用型CAR-T细胞产品在中国内地进程
2024-03-01 国内第五款,科济药业BCMA CAR-T疗法获批上市
2024-03-01 科济药业:CAR-T产品泽沃基奥仑赛注射液在中国获批上市

#热门话题



tg-me.com/readhub_cn/264230
Create:
Last Update:

科济药业 Claudin18.2 CAR-T 拟纳入优先审评,针对胃癌

舒瑞基奥仑赛注射液(CT041)是科济药业开发的靶向Claudin18.2蛋白的自体CAR-T细胞产品,该蛋白在胃癌和胰腺癌中表达率超50%,适合治疗晚期胃/食管胃结合部腺癌。2020年9月,CT041获美国FDA孤儿药资格认定用于胃癌/食管胃结合部腺癌治疗。

媒体报道
科济药业-B现涨逾3% 子公司申报的舒瑞基奥仑赛注射液拟纳入优先审评 新浪科技
科济药业 Claudin18.2 CAR-T 拟纳入优先审评,针对胃癌 医药魔方
治疗胃癌,科济药业CAR-T细胞疗法拟纳入优先审评! 医药魔方
潜在首款!科济药业CAR-T疗法拟纳入优先审评 医药魔方

事件追踪
2025-02-26 科济药业引入珠海软银欣创投资以加速通用型CAR-T细胞产品在中国内地进程
2024-03-01 国内第五款,科济药业BCMA CAR-T疗法获批上市
2024-03-01 科济药业:CAR-T产品泽沃基奥仑赛注射液在中国获批上市

#热门话题

BY Readhub


Warning: Undefined variable $i in /var/www/tg-me/post.php on line 283

Share with your friend now:
tg-me.com/readhub_cn/264230

View MORE
Open in Telegram


Readhub Telegram | DID YOU KNOW?

Date: |

How To Find Channels On Telegram?

There are multiple ways you can search for Telegram channels. One of the methods is really logical and you should all know it by now. We’re talking about using Telegram’s native search option. Make sure to download Telegram from the official website or update it to the latest version, using this link. Once you’ve installed Telegram, you can simply open the app and use the search bar. Tap on the magnifier icon and search for a channel that might interest you (e.g. Marvel comics). Even though this is the easiest method for searching Telegram channels, it isn’t the best one. This method is limited because it shows you only a couple of results per search.

Readhub from us


Telegram Readhub
FROM USA